This is an archived document. The links
and content are no longer being updated.
Table 8. Resistance to Isoniazid with or without Rifampin Resistance in Reported
TB Cases with No Previous TB by Origin: United States, 1993-2002
Return to 2002 Surveillance Report
Year |
Resistant to Isoniazid1 |
Resistant to Isoniazid and Rifampin1 |
Total Cases2 |
U. S.-born |
Foreign-born3 |
Total Cases2 |
U. S.-born |
Foreign-born3 |
No. |
% |
No. |
% |
No. |
% |
No. |
% |
No. |
% |
No. |
% |
1993 |
1,401 |
8.4 |
805 |
6.8 |
579 |
12.4 |
410 |
2.5 |
302 |
2.6 |
105 |
2.3 |
1994 |
1,355 |
8.3 |
709 |
6.4 |
632 |
12.1 |
352 |
2.2 |
238 |
2.2 |
109 |
2.1 |
1995 |
1,172 |
7.3 |
554 |
5.4 |
617 |
11.0 |
252 |
1.6 |
168 |
1.6 |
84 |
1.5 |
1996 |
1,136 |
7.4 |
494 |
5.2 |
639 |
11.3 |
206 |
1.3 |
104 |
1.1 |
101 |
1.8 |
1997 |
1,080 |
7.5 |
437 |
5.0 |
639 |
11.2 |
155 |
1.1 |
76 |
0.9 |
79 |
1.4 |
1998 |
1,012 |
7.5 |
366 |
4.7 |
644 |
11.3 |
131 |
1.0 |
55 |
0.7 |
75 |
1.3 |
1999 |
904 |
7.1 |
284 |
4.0 |
618 |
11.0 |
128 |
1.0 |
39 |
0.6 |
89 |
1.6 |
2000 |
893 |
7.5 |
270 |
4.3 |
620 |
11.0 |
121 |
1.0 |
38 |
0.6 |
83 |
1.5 |
2001 |
806 |
7.1 |
245 |
4.4 |
560 |
9.6 |
116 |
1.0 |
34 |
0.6 |
82 |
1.4 |
2002 |
778 |
7.5 |
197 |
4.0 |
574 |
10.6 |
121 |
1.2 |
37 |
0.8 |
83 |
1.5 |
1Isolates may be resistant
to other drugs. 2Includes persons of unknown country of birth.
3Includes persons born outside the United States, American Samoa,
the Federated States of Micronesia, Guam, the Republic of the Marshall Islands,
Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto
Rico, the Republic of Palau, the U.S. Virgin Islands, and U.S. minor and
outlying Pacific islands.
Note: Data for all years updated through March 28, 2003.
More than 85% of all cases in each group had drug susceptibility test results
reported for an initial isolate.
See Surveillance Slides #18, #19, #20, and #21. |
Last Reviewed: 05/18/2008 Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Back to Top of Page
You will need Adobe Acrobat Reader
v5.0 or higher to read pages that are in PDF format. Download the Adobe Acrobat Reader.
If you have difficulty accessing any
material on the DTBE Web site because of a disability, please contact
us in writing or via telephone and we will work with you to make the information
available.
Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: tbinfo@cdc.gov
|
Home | Site Map
| Contact Us
Accessibility
| Privacy Policy Notice |
FOIA
| USA.gov
CDC Home |
Search |
Health Topics A-Z
Centers for Disease Control & Prevention
National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination Please send comments/suggestions/requests to:
CDCINFO@cdc.gov
|